Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycleexit, is mediated by the protein phosphatase 2A/B55α holoenzyme

Molecular and Cellular Biology

Volumn 33, Issue 16, 2013, Pages 3330-3342

  Kurimchak, Alison ^a   Haines, Dale S ^a   Garriga, Judit ^a   Wu, Shufang ^b   Luca, Francesco De ^b   Sweredoski, Michael J ^c   Deshaies, Raymond J ^d   Hess, Sonja ^c   Graña, Xavier ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; MYC PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P107;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CYCLE; CONTROLLED STUDY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION;

EID: 84881283766     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00082-13     Document Type: Article

References (53)

1. Dick FA. 2007. Structure-function analysis of the retinoblastoma tumor suppressor protein-is the whole a sum of its parts. Cell Div. 2:26.
2. Graña X, Garriga J, Mayol X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17:3365-3383.
3. Sotillo E, Graña X. 2010. Escape from cellular quiescence, p 3-22. In Enders GH (ed), Cell cycle deregulation in cancer. Springer Publishing, New York, NY.
4. Kurimchak A, Graña X. 2012. PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates. Gene 499:1-7.
5. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
6. Rowland BD, Bernards R. 2006. Re-evaluating cell-cycle regulation by E2Fs. Cell 127:871-874.
7. Fisher RP. 2012. The CDK network: linking cycles of cell division and gene expression. Genes Cancer 3:731-738.
8. Kurimchak A, Graña X. 2012. PP2A counterbalances phosphorylation of pRB and mitotic proteins by multiple CDKs: potential implications for PP2A disruption in cancer. Genes Cancer 3:739-748.
9. Enders GH. 2012. Mammalian interphase cdks: dispensable master regulators of the cell cycle. Genes Cancer 3:614-618.
10. MacDonald J, Dick FA. 2012. Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer 3:619-633.
11. Calbó J, Parreño M, Sotillo E, Yong T, Mazo A, Garriga J, Graña X. 2002. G1 cyclin/CDK coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J. Biol. Chem. 277:50263-50274.
12. Graña X. 2008. Downregulation of the phosphatase nuclear targeting subunit (PNUTS) triggers pRB dephosphorylation and apoptosis in pRB positive tumor cell lines. Cancer Biol. Ther. 7:842-844.
13. Kolupaeva V, Janssens V. 2013. PP1 and PP2A phosphatases- cooperating partners in modulating retinoblastoma protein activation. FEBS J. 280:627-643.
14. Ludlow JW, Glendening CL, Livingston DM, DeCarprio JA. 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13:367-372.
15. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555-569.
16. Hirschi A, Cecchini M, Steinhardt RC, Schamber MR, Dick FA, Rubin SM. 2010. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat. Struct. Mol. Biol. 17:1051- 1057.
17. Garriga J, Jayaraman AL, Limon A, Jayadeva G, Sotillo E, Truongcao M, Patsialou A, Wadzinski BE, Graña X. 2004. A dynamic equilibrium between CDKs and PP2A modulates phosphorylation of pRB, p107 and p130. Cell Cycle 3:1320-1330.
18. Virshup DM, Shenolikar S. 2009. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 33:537-545.
19. Eichhorn PJ, Creyghton MP, Bernards R. 2009. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 1795:1-15.
20. Jayadeva G, Kurimchak A, Garriga J, Sotillo E, Davis AJ, Haines DS, Mumby M, Graña X. 2010. B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation. J. Biol. Chem. 285:29863-29873.
21. Magenta A, Fasanaro P, Romani S, Di Stefano V, Capogrossi MC, Martelli F. 2008. Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol. Cell. Biol. 28:873-882.
22. Voorhoeve PM, Watson RJ, Farlie PG, Bernards R, Lam EW. 1999. Rapid dephosphorylation of p107 following UV irradiation. Oncogene 18:679-688.
23. Vuocolo SC, Purev E, Zhang D, Bartek J, Hansen K, Soprano DR, Soprano KJ. 2003. Protein phosphatase 2A associates with Rb2/p130 and mediates retinoic acid-induced growth suppression of ovarian carcinoma cells. J. Biol. Chem. 278:41881-41889.
24. Dailey L, Laplantine E, Priore R, Basilico C. 2003. A network of tran-scriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell Biol. 161:1053-1066.
25. Kolupaeva V, Laplantine E, Basilico C. 2008. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One 3:e3447. doi:10.1371/journal.pone.0003447.
26. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRb-related p130 and p107 proteins in limb development. Genes Dev. 10:1633-1644.
27. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16:1446-1465.
28. Wu S, Morrison A, Sun H, De Luca F. 2011. Nuclear factor-B (NF-B) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2. J. Biol. Chem. 286:24726-24734.
29. Haines DS, Lee JE, Beauparlant SL, Kyle DB, den Besten W, Sweredoski MJ, Graham RLJ, Hess S, Deshaies RJ. 2012. Protein interaction profiling of the p97 adaptor UBXD1 uncovers a role for the complex in ERGIC- 53 trafficking. Mol. Cell. Proteomics 11:M111.016444. doi:10.1074 /mcp.M111.016444.
30. Donner AJ, Ebmeier CC, Taatjes DJ, Espinosa JM. 2010. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 17:194-201.
31. Keskin H, Garriga J, Georlette D, Graña X. 2012. Complex effects of flavopiridol on the expression of primary response genes. Cell Div. 7:11.
32. Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. 2004. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp. Cell Res. 297:152-164.
33. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13:1361- 1366.
34. Aikawa T, Segre GV, Lee K. 2001. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J. Biol. Chem. 276:29347-29352.
35. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A. 2002. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J. Cell Sci. 115: 553-562.
36. Tran T, Kolupaeva V, Basilico C. 2010. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G(2) arrest in RCS chondrocytes. Cell Cycle 9:4379-4386.
37. Li S, Brignole C, Marcellus R, Thirlwell S, Binda O, McQuoid MJ, Ashby D, Chan H, Zhang Z, Miron MJ, Pallas DC, Branton PE. 2009. The adenovirus E4orf4 protein induces G2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J. Virol. 83:8340-8352.
38. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, Chen R, Washburn MP, Liu XS, DeCaprio JA. 2007. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol. Cell 26:539-551.
39. Mayol X, Garriga J, Graña X. 1996. G1 cyclin/Cdk-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13:237-246.
40. Lorca T, Castro A. 2012. Deciphering the new role of the Greatwall/PP2A pathway in cell cycle control. Genes Cancer 3:712-720.
41. Laplantine E, Rossi F, Sahni M, Basilico C, Cobrinik D. 2002. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J. Cell Biol. 158:741-750.
42. Yan Y, Frisen J, Lee MH, Massague J, Barbacid M. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973-983.
43. Yeh N, Miller JP, Gaur T, Capellini TD, Nikolich-Zugich J, de la Hoz C, Selleri L, Bromage TG, van Wijnen AJ, Stein GS, Lian JB, Vidal A, Koff A. 2007. Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130. Mol. Cell. Biol. 27:5161-5171.
44. Lorca T, Castro A. 2013. The Greatwall kinase: a new pathway in the control of the cell cycle. Oncogene 32:537-543.
45. Castilho PV, Williams BC, Mochida S, Zhao Y, Goldberg ML. 2009. The Mphase kinase Greatwall (Gwl) promotes inactivation of PP2A/B55delta, a phosphatase directed against CDK phosphosites. Mol. Biol. Cell 20: 4777-4789.
46. Mochida S, Ikeo S, Gannon J, Hunt T. 2009. Regulated activity of PP2A-B55 delta is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts. EMBO J. 28:2777-2785.
47. Vigneron S, Brioudes E, Burgess A, Labbe JC, Lorca T, Castro A. 2009. Greatwall maintains mitosis through regulation of PP2A. EMBO J. 28: 2786-2793.
48. Gharbi-Ayachi A, Labbe JC, Burgess A, Vigneron S, Strub JM, Brioudes E, Van-Dorsselaer A, Castro A, Lorca T. 2010. The substrate of Greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A. Science 330:1673-1677.
49. Mochida S, Maslen SL, Skehel M, Hunt T. 2010. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 330:1670-1673.
50. Manchado E, Guillamot M, de Carcer G, Eguren M, Trickey M, Garcia- Higuera I, Moreno S, Yamano H, Canamero M, Malumbres M. 2010. Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55, phosphatase. Cancer Cell 18:641-654.
51. Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, Goris J, Trinkle-Mulcahy L, Lamond AI, Poser I, Hyman AA, Mechtler K, Peters JM, Gerlich DW. 2010. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell Biol. 12:886-893.
52. Bhattacharya S, Garriga J, Calbo J, Yong T, Haines DS, Graña X. 2003. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22:2443-2451.
53. Tedesco D, Lukas J, Reed SI. 2002. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the proteinubiquitin ligase SCF(Skp2). Genes Dev. 16:2946-2957.